CLASSYS Inc

CLASSYS Inc

214150 · KQ · Healthcare / Medical Devices

23,800.00KRW-300.00 (-1.24%)

Price History

Full chart

Market Stats

Previous Close24,100.00
Open22,600.00
Day Range21,650.00 – 24,550.00
52-Week Range29,700.00 – 77,600.00
Volume354.28K
Market Cap2.01T
P/E (TTM)0.00
Forward P/E0.00
Dividend Yield3.19%
Beta0.66
50-Day Avg35,726.00
200-Day Avg49,829.50

About

CLASSYS Inc. provides medical aesthetics devices worldwide. The company offers ULTRAFORMER MPT, a solution for eyebrow lifting; ULTRAFORMER III, an ultrasound surgical device used for tissue coagulation in eyelid lifting, and for skin tightening and improving subcutaneous tissue elasticity in the face (cheeks), abdomen, and thighs; VOLNEWMER, a monopolar radiofrequency therapeutic equipment used to coagulate skin tissue; Secret RF, a device that delivers radio frequency energy into the skin; Secret PRO, a multiple fractional device that delivers micro-level laser beams fractionally to the tissue; Secret DUO, a multi-functional device that delivers high-frequency energy through needle electrodes; and Fortra, a 4 wavelengths diode laser. It also provides SCIZER and CLATUU Alpha for non-invasive subcutaneous fat reduction; Ulfit, a medical device used to improve skin elasticity and subcutaneous tissue in the abdomen and thighs; Refit, a medical device that uses RF and negative pressure to increase tissue temperature and blood flow, relieving pain in the treated area; AQUAPURE, a combination of four handpieces used for acne suction, muscle pain relief, and other pain relief; FORSHAPE, an RF treatment system used to increase metabolism, blood circulation, and tissue recovery; and INTRASURE for lifting, wrinkle reduction, body contouring, and cellulite reduction. In addition, the company offers AQUAPURE II, which exfoliates hyper-keratinized dead skin cells; Reepot, a medical device that delivers energy to tissue; veloce, which enhances treatment results; Pento, a laser surgical device for tissue incision, destruction, and removal; and curas hybrid laser system. Further, it sells cosmetics. The company offers its products under the Classys, Cluederm, and Skederm brands. It serves distributors, clinics, hospitals, and direct end users. The company was founded in 2007 and is headquartered in Seoul, South Korea. CLASSYS Inc. is a subsidiary of BCPE Centur Investments, LP.

Company Details

  • SectorHealthcare
  • IndustryMedical Devices
  • CEOMr. Yoon Jun-oh
  • Employees0
  • Headquarters208, Teheran-ro, Seoul, South Korea, Korea
  • Websitehttps://classys.co.kr

Leadership

  • Mr. Yoon Jun-ohChief Executive Officer
  • Dr. Taek-Soo KimCTO & Head of Research & Development

Financials

Income Statement

Currency: KRW2015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue-27.24B34.87B47.48B81.13B76.46B100.60B141.80B180.12B242.94B336.82B
Growth (%)--+27.99%+36.18%+70.87%-5.76%+31.57%+40.96%+27.02%+34.87%+38.64%
Cost of Revenue-8.70B10.70B12.73B17.23B15.50B22.74B33.64B39.67B51.81B75.73B
Gross Profit-18.55B24.17B34.75B63.91B60.96B77.85B108.17B140.45B191.13B261.09B
Gross Margin-68.07%69.31%73.18%78.77%79.73%77.39%76.28%77.97%78.67%77.52%
Operating Expense-18.60B13.37B17.27B22.20B20.35B26.14B39.29B50.83B80.37B90.49B
Operating Income-45.53M-55.34M10.80B17.48B41.71B40.61B51.71B68.88B89.62B110.75B170.60B
Operating Margin--0.20%30.98%36.81%51.41%53.11%51.41%48.57%49.76%45.59%50.65%
EBITDA-------103.27B100.08B137.19B185.69B
EBITDA Margin-------72.82%55.56%56.47%55.13%
Net Income63.66M80.85M-5.13B14.86B33.39B38.16B43.80B75.38B74.23B97.88B131.94B
Net Income Margin-0.30%-14.71%31.30%41.16%49.91%43.54%53.16%41.21%40.29%39.17%
R&D-1.08B1.53B1.53B1.92B3.12B4.70B4.43B9.20B12.62B17.44B
R&D as % of Total Revenue-3.96%4.38%3.22%2.37%4.07%4.67%3.12%5.11%5.19%5.18%
Interest Expense0000260.58M168.91M93.05M2.61B1.96B2.04B2.42B
Interest Expense % of Total Revenue-0.00%0.00%0.00%0.32%0.22%0.09%1.84%1.09%0.84%0.72%

Balance Sheet

Currency: KRW2015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets11.90B12.01B63.16B75.68B113.66B137.53B216.38B331.41B375.44B608.38B704.65B
Total Liabilities1.39B1.42B28.07B24.63B25.74B13.77B52.63B101.86B91.94B155.73B152.98B
Total Equity10.52B10.60B35.09B51.04B87.92B123.76B163.74B229.55B283.50B453.96B552.97B
Cash259.39M247.17M19.22B10.47B33.98B64.38B42.79B26.00B18.34B22.75B37.52B
Total Debt-1.38B18.46B13.04B9.68B171.55M-----
Net Debt-------40.80B46.06B67.58B48.99B

Cash Flow

Currency: KRW2015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow32.25M5.77B8.60B15.99B39.03B38.13B36.37B54.75B64.63B102.80B163.94B
Investing Cash Flow-11.57B-484.73M-20.63B-20.26B-12.65B6.66B-92.47B-91.99B-48.16B-82.25B-
Financing Cash Flow11.80B-33.18M19.40B-4.44B-2.52B-12.18B30.72B21.06B-25.64B-16.74B-
Capital Expenditure0166.41M31.71B14.77B6.19B791.89M90.91B71.24B6.11B10.78B19.25B
Free Cash Flow----34.92B37.14B3.33B26.76B58.52B92.02B144.68B
Dividends Paid-483.78M483.78M483.78M867.62M2.96B3.88B4.27B7.47B12.80B16.83B
FCF to OCF----89.46%97.42%9.15%48.87%90.54%89.51%88.26%
Dividend Paid to FCF----2.48%7.97%116.61%15.96%12.77%13.91%11.64%

Earnings

Report DateMay 15, 2017Aug 15, 2017Nov 15, 2017Mar 7, 2018May 15, 2018Aug 14, 2018Nov 12, 2018Jan 31, 2019May 14, 2019Aug 13, 2019Nov 13, 2019Feb 5, 2020May 12, 2020Aug 12, 2020Nov 12, 2020Feb 3, 2021May 13, 2021Aug 13, 2021Nov 11, 2021Feb 15, 2022May 13, 2022Aug 16, 2022Nov 11, 2022Feb 15, 2023May 15, 2023Aug 14, 2023Nov 14, 2023Mar 20, 2024May 14, 2024Aug 14, 2024Nov 14, 2024Mar 21, 2025May 12, 2025Aug 14, 2025Nov 14, 2025Mar 23, 2026May 15, 2026Aug 14, 2026
EPS Estimate----------87.00111.00110.00---179.00135.14151.50162.81198.05243.73163.63234.00247.00206.58183.62278.33260.40397.87329.66343.68468.99537.86535.831169.28488.27654.63
EPS Actual2.3151.0039.00-203.6731.0062.0045.35100.0093.00119.00149.00161.88176.0073.00136.00203.98148.00186.00193.00149.07198.00213.00289.00465.00292.00288.00328.00244.00406.00413.00258.00432.00452.38401.00502.00650.00514.00434.00
Surprise----------71.26%45.84%60.00%----17.32%37.63%27.39%-8.44%-0.03%-12.61%76.62%98.72%18.22%39.41%78.63%-12.33%55.91%3.80%-21.74%25.70%-3.54%-25.45%-6.31%-44.41%5.27%-33.70%
TimingAfter-hoursAfter-hoursAfter-hoursAfter-hoursPre-marketPre-marketAfter-hoursAfter-hoursPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketAfter-hoursPre-marketPre-marketPre-marketPre-market-After-hoursPre-market-After-hoursPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-market

Key Statistics & Ratios

Market Cap2.01T
Enterprise Value2.01T
Trailing P/E0.00
Forward P/E0.00
Price / Sales5.43
Price / Book3.64
Revenue (TTM)369.11B
Gross Profit (TTM)277.31B
EBITDA185.40B
Profit Margin37.29%
Operating Margin41.64%
Return on Equity25.61%
Return on Assets15.16%
Shares Outstanding65.22M
Shares Float21.84M
Beta0.66
Dividend Yield3.19%
Dividend Rate1,000.00
Payout Ratio47.62%

Dividends

20251×
1000.00Dec 29, 2025
20241×
257.00Dec 27, 2024
20231×
200.00Dec 27, 2023
20221×
116.00Dec 28, 2022
20211×
66.00Dec 29, 2021
20201×
60.00Dec 29, 2020
20191×
46.00Dec 27, 2019
20181×
14.00Dec 27, 2018
20171×
8.00Dec 27, 2017